Search clinical trials for: Acute Normovolemic Hemodilution (ANH)

Total 1922 results

Sun Yat-sen University

Recruiting

Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC

Nasopharyngeal Carcinoma

China
Nektar Therapeutics

Completed

A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine (ATTAIN)

Breast Cancer | Metastasis

United States, Australia, Belgium, Canada, France, Israel, Italy, Portugal, Spain, United Kingdom
Spanish Breast Cancer Research Group
Sanofi; Pfizer; Hoffmann-La Roche

Completed

EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer

Breast Cancer

Spain
Inova Health Care Services

Completed

Continuous Subpleural Infusion of Bupivacaine

Postoperative Pain

United States
Dana-Farber Cancer Institute

Terminated

Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study

Squamous Cell Carcinoma of the Head and Neck | Human Papilloma Virus

United States
Sanofi
Cancer International Research Group (CIRG)

Completed

Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer

Breast Neoplasms

United States, France, Brazil, Romania, Russian Federation, Australia, Spain, Sweden, Turkey, India, Slovakia, Taiwan, Belgium, Czech Republic, Tunisia, Uruguay, Argentina, Croatia, Austria, Egypt, Greece, Hungary, Ireland, Israel, Italy, Mexic... and more
University of Michigan Rogel Cancer Center

Terminated

Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE)

Cancer of Larynx

United States
Geno LLC

Withdrawn

Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide (EAGLE)

Pulmonary Arterial Hypertension

United States
Centre Jean Perrin

Completed

Breast Cancer Treated by Neoadjuvant Chemotherapy

Individualized Chemotherapy

France
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Lung Cancer

United States
Northwestern University
National Cancer Institute (NCI)

Completed

Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer

Breast Cancer

United States
Radboud University Medical Center
Sanofi; Amgen

Completed

Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer. (INTENS)

Breast Cancer

Netherlands
Organon and Co

Completed

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05690 (Care Program) (P05710) (Care)

Pregnancy | Neonates
Columbia University
Genentech, Inc.

Terminated

Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer

Prostate Cancer

United States
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital

Completed

Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer

Prostate Cancer

United States
Sanofi

Completed

Study to Evaluate the Response Rate to Therapy With Docetaxel and Cisplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck (DECIDE)

Squamous Cell Carcinoma of Head and Neck

Pakistan
Air Force Military Medical University, China

Not yet recruiting

HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic Patients

Liver Cirrhoses | Esophageal Varices | Variceal Hemorrhage

China
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

Childhood Cancer | Multiple Diseases

United States
Hongqian Guo

Active, not recruiting

Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer

Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel

China
Massachusetts General Hospital
Gilead Sciences; Brigham and Women's Hospital

Completed

Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy and Switch to an Elvitegravir-based Regimen

HIV Disease

United States
Seoul National University Bundang Hospital
Chong Kun Dang Pharmaceutical Corp.

Unknown

Immediate Release Versus Slow Release Carvedilol in Heart Failure (SLOW-HF)

Heart Failure With Reduced Ejection Fraction

Korea, Republic of
Southwest Oncology Group
National Cancer Institute (NCI); Cancer and Leukemia Group B; North Central Cancer...

Completed

S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy

Prostate Cancer

United States
Columbia University

Unknown

Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III)

Pancreatic Cancer Stage III | Pancreatic Cancer Stage II

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer

Gastric Cancer | Esophageal Cancer

United States
National University Hospital, Singapore

Completed

The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian Patients

Breast Cancer | Non Small Cell Lung Cancer

Singapore
Calithera Biosciences, Inc

Completed

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

Renal Cell Carcinoma | Non Small Cell Lung Cancer | Mesothelioma | Solid Tumors | Triple-Negative Breast Cancer | Fumarate Hydratase (FH)-Deficient Tumors | Succinate Dehydrogenase (SDH)-Deficient Gastrointestinal Stromal Tumors (GIST) | Succinate Dehydrogenase (SDH)-Deficient Non-gastrointestinal... and other conditions

United States
European Organisation for Research and Treatment...
Sanofi; Novartis; Roche Pharma AG; Breast International Group; Agendia

Completed

Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes (MINDACT)

Breast Cancer

Netherlands
Xiayun He, MD

Completed

Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Xijing Hospital

Completed

Neoadjuvant Endostatin and Chemotherapy for Breast Cancer

Breast Cancer

China
Fudan University

Recruiting

Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer (PANSY)

Breast Cancer

China
Merck Sharp & Dohme LLC

Terminated

Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007)

Mental Disorders | Sleep Disorders, Intrinsic | Dyssomnias | Sleep Initiation and Maintenance Disorders | Sleep Disorders
Mothaffar Rimawi
Baylor College of Medicine

Completed

Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients (TACAC)

Breast Cancer

United States
Fudan University

Completed

Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER)

Primary Breast Cancer
Krankenhaus Nordwest

Completed

5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer

Gastric Cancer

Germany
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company; United States Department of Defense

Completed

Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)

Lung Cancer

United States
ArQule, Inc. (a wholly owned subsidiary of Merck...

Completed

Erlotinib Plus Tivantinib (ARQ 197) Versus Single Agent Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Metastatic Non-Small Cell Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

GTX-RT in Borderline Resectable Pancreatic Cancer

Pancreatic Cancer

United States
National Cancer Institute, Naples

Withdrawn

CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer (CETRA)

Breast Cancer

Italy
Sanofi
Cancer International Research Group (CIRG)

Completed

Docetaxel in Node Positive Adjuvant Breast Cancer (TAX316)

Breast Cancer

United States, France, Canada, Brazil, Poland, Germany, Portugal, Spain, Sweden, Slovakia, Czech Republic, Uruguay, Argentina, Egypt, Hungary, Israel, South Africa, Austria, Greece, United Kingdom
Saint Petersburg State University, Russia
Ural State Medical University

Recruiting

BTA vs Baclofen for Pelvic Myofascial Pain Syndrome (BvsB)

Chronic Pain | Pelvic Floor Disorders | Myofascial Pain Syndrome | Myofascial Trigger Point Pain | Chronic Pelvic Pain Syndrome

Russian Federation
Kosei Hasegawa, MD, PhD

Recruiting

Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian Cancer

Carcinoma, Ovarian Epithelial

Japan
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Pyrotinib as Neoadjuvant Agent for Non-objective Response HER2-positive Early Breast Cancer

Breast Cancer

China
Albert Einstein College of Medicine
National Cancer Institute (NCI)

Terminated

Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery

Uterine Corpus Leiomyosarcoma | Stage IIA Uterine Sarcoma | Stage IIB Uterine Sarcoma | Stage IIIA Uterine Sarcoma | Stage IIIB Uterine Sarcoma | Stage IIIC Uterine Sarcoma | Stage IVA Uterine Sarcoma | Stage IVB Uterine Sarcoma | Stage IA Uterine Sarcoma | Stage IB Uterine Sarcoma | Stage IC Uterine Sarcoma

United States
University of Alberta

Completed

Sex Differences in Sympathetic Activity and Vascular Reactivity During Acute and Chronic Hypoxia.

Vasodilation | Vasoconstriction

Canada
The First Hospital of Jilin University

Unknown

Apatinib Combined With Chemotherapy for NSCLC Patients Without T790M Mutation

Non Small Cell Lung Cancer

China
Centre Oscar Lambret
National Cancer Institute, France

Terminated

Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer. (E-DIS)

Squamous Cell Carcinoma of Esophagus

France
Wake Forest University Health Sciences
The Hershey Company

Completed

Effects of a Cocoa Shot on the Human Brain 2

Caffeine

United States
Shanghai Jiao Tong University School of Medicine

Terminated

Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer (NATT)

Breast Cancer

China
Sidney Kimmel Cancer Center at Thomas Jefferson...

Withdrawn

Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis

Kidney Transplantation | Plasmapheresis

United States
Memorial Sloan Kettering Cancer Center
Sanofi; Genentech, Inc.

Completed

Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma

Stomach Neoplasms | Esophageal Neoplasms

United States

Search clinical trials for: Acute Normovolemic Hemodilution (ANH)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations